PT2233153E - Vacina de rotavírus que induz protecção cruzada heterotípica - Google Patents

Vacina de rotavírus que induz protecção cruzada heterotípica Download PDF

Info

Publication number
PT2233153E
PT2233153E PT101599496T PT10159949T PT2233153E PT 2233153 E PT2233153 E PT 2233153E PT 101599496 T PT101599496 T PT 101599496T PT 10159949 T PT10159949 T PT 10159949T PT 2233153 E PT2233153 E PT 2233153E
Authority
PT
Portugal
Prior art keywords
cross protection
rotavirus vaccine
vaccine inducing
heterotypic cross
heterotypic
Prior art date
Application number
PT101599496T
Other languages
English (en)
Inventor
Brigitte Desiree Alberte Colau
Beatrice Arsene Virginie De Vos
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0516944A external-priority patent/GB0516944D0/en
Priority claimed from GB0521164A external-priority patent/GB0521164D0/en
Priority claimed from GB0608962A external-priority patent/GB0608962D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of PT2233153E publication Critical patent/PT2233153E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12311—Rotavirus, e.g. rotavirus A
    • C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT101599496T 2005-08-17 2006-08-15 Vacina de rotavírus que induz protecção cruzada heterotípica PT2233153E (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0516944A GB0516944D0 (en) 2005-08-17 2005-08-17 Vaccine
GB0521164A GB0521164D0 (en) 2005-10-18 2005-10-18 Vaccine
GB0608962A GB0608962D0 (en) 2006-05-05 2006-05-05 Vaccine

Publications (1)

Publication Number Publication Date
PT2233153E true PT2233153E (pt) 2015-04-20

Family

ID=37757924

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101599496T PT2233153E (pt) 2005-08-17 2006-08-15 Vacina de rotavírus que induz protecção cruzada heterotípica

Country Status (25)

Country Link
US (1) US20090028828A1 (pt)
EP (2) EP1915173A2 (pt)
JP (1) JP5519934B2 (pt)
KR (1) KR20080036648A (pt)
AR (1) AR054916A1 (pt)
AU (1) AU2006281566B2 (pt)
BR (1) BRPI0615203A2 (pt)
CA (1) CA2619751C (pt)
CR (1) CR9759A (pt)
CY (1) CY1116135T1 (pt)
DK (1) DK2233153T3 (pt)
EA (1) EA014328B1 (pt)
ES (1) ES2534637T3 (pt)
HR (1) HRP20150310T1 (pt)
IL (1) IL189289A0 (pt)
MA (1) MA29700B1 (pt)
MX (1) MX2008002270A (pt)
NO (1) NO20080754L (pt)
PE (1) PE20070235A1 (pt)
PL (1) PL2233153T3 (pt)
PT (1) PT2233153E (pt)
SG (1) SG163571A1 (pt)
SI (1) SI2233153T1 (pt)
TW (1) TW200740457A (pt)
WO (1) WO2007020078A2 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0107510D0 (en) 2001-03-26 2001-05-16 Univ Bristol New elongase gene and a process for the production of -9-polyunsaturated fatty acids
WO2009042202A2 (en) * 2007-09-25 2009-04-02 Aridis Pharmaceuticals Formulations for preservation of rota virus
US9311112B2 (en) * 2009-03-16 2016-04-12 Apple Inc. Event recognition
BR112013027457A2 (pt) * 2011-04-28 2019-09-24 Int Medica Foundation preparação de vacina, e, métodos de fabricar uma preparação de vacina, e de vacinar um mamífero
WO2013160913A1 (en) * 2012-04-23 2013-10-31 Bharat Biotech International Limited Rotavirus vaccine compositions and process for preparing the same
US10548970B2 (en) 2015-10-05 2020-02-04 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Human rotavirus G9P[6] strain and use as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2121841T3 (es) * 1990-11-16 1998-12-16 Childrens Hosp Medical Center Una vacuna para proporcionar proteccion inmunologica contra enfermedades de rotavirus en humanos.
PT1212084E (pt) * 1999-08-17 2006-07-31 Glaxosmithkline Biolog Sa Metodos para separar variantes do rotavirus e vacina do rotavirus vivo atenuado
NZ545639A (en) * 2003-09-02 2009-04-30 Glaxosmithkline Biolog Sa Cross-protective live attenuated human rotavirus vaccine

Also Published As

Publication number Publication date
WO2007020078A2 (en) 2007-02-22
MX2008002270A (es) 2008-03-27
AU2006281566A1 (en) 2007-02-22
AR054916A1 (es) 2007-07-25
EP2233153A1 (en) 2010-09-29
EP1915173A2 (en) 2008-04-30
MA29700B1 (fr) 2008-08-01
HRP20150310T1 (hr) 2015-06-19
EA200800320A1 (ru) 2008-10-30
SI2233153T1 (sl) 2015-05-29
WO2007020078A3 (en) 2007-05-24
IL189289A0 (en) 2008-06-05
CA2619751C (en) 2016-07-05
PE20070235A1 (es) 2007-04-04
TW200740457A (en) 2007-11-01
NO20080754L (no) 2008-05-15
JP2009504701A (ja) 2009-02-05
CA2619751A1 (en) 2007-02-22
EA014328B1 (ru) 2010-10-29
CY1116135T1 (el) 2017-02-08
PL2233153T3 (pl) 2015-06-30
BRPI0615203A2 (pt) 2011-05-10
DK2233153T3 (da) 2015-04-27
JP5519934B2 (ja) 2014-06-11
US20090028828A1 (en) 2009-01-29
ES2534637T3 (es) 2015-04-27
KR20080036648A (ko) 2008-04-28
AU2006281566B2 (en) 2011-09-01
EP2233153B1 (en) 2015-01-21
CR9759A (es) 2008-05-05
SG163571A1 (en) 2010-08-30

Similar Documents

Publication Publication Date Title
IL192084A0 (en) Vaccine
GB0504436D0 (en) Vaccine
ZA200804918B (en) Therapeutic vaccine
IL186600A0 (en) Novel vaccine formulations
IL186828A0 (en) Vaccine composition
GB0513421D0 (en) Vaccines
GB2439242B (en) Protection sleeve
IL189289A0 (en) Rotavirus vaccine inducing heterotypic cross protection
GB0524409D0 (en) Vaccines
ZA200801405B (en) Rotavirus vaccine inducing heterotypic cross protection
EP2054081A4 (en) VACCINE AGAINST THE JC VIRUS
GB0515135D0 (en) Vaccine
GB0524408D0 (en) Vaccines
ZA200709207B (en) Vaccine
GB0810662D0 (en) Vaccine
ZA200709210B (en) Vaccine
GB0511203D0 (en) Vaccines
GB0526412D0 (en) Vaccine
GB0503000D0 (en) Anti-atheroma vaccine
GB0523445D0 (en) Vaccine
GB0515242D0 (en) Vaccine
IL186591A0 (en) Vaccine
IL186586A0 (en) Vaccine
GB0509010D0 (en) Vaccine
GB0513194D0 (en) Vaccine